Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.

MLA

Rangwala, Reshma, et al. “Phase I Trial of Hydroxychloroquine with Dose-Intense Temozolomide in Patients with Advanced Solid Tumors and Melanoma.” Autophagy, vol. 10, no. 8, Aug. 2014, pp. 1369–79. EBSCOhost, https://doi.org/10.4161/auto.29118.

APA

Rangwala, R., Leone, R., Yunyoung C. Chang, Fecher, L. A., Schuchter, L. M., Kramer, A., Kay-See Tan, Heitjan, D. F., Rodgers, G., Gallagher, M., Shengfu Piao, Troxel, A. B., Evans, T. L., Demichele, A. M., Nathanson, K. L., O’Dwyer, P. J., Kaiser, J., Pontiggia, L., Davis, L. E., & Amaravadi, R. K. (2014). Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy, 10(8), 1369–1379. https://doi.org/10.4161/auto.29118

Chicago

Rangwala, Reshma, Robert Leone, Yunyoung C. Chang, Leslie A. Fecher, Lynn M. Schuchter, Amy Kramer, Kay-See Tan, et al. 2014. “Phase I Trial of Hydroxychloroquine with Dose-Intense Temozolomide in Patients with Advanced Solid Tumors and Melanoma.” Autophagy 10 (8): 1369–79. doi:10.4161/auto.29118.